FLR

(2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid

Find entries where: FLR

is present as a standalone ligand in 3 entries

Find related ligands:

Chemical Component Summary
Name	(2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid
Synonyms	Flurbirprofen, R-form
Identifiers	(2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid
Formula	C₁₅ H₁₃ F O₂
Molecular Weight	244.261
Type	NON-POLYMER
Isomeric SMILES	C[C@H](c1ccc(c(c1)F)c2ccccc2)C(=O)O
InChI	InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m1/s1
InChIKey	SYTBZMRGLBWNTM-SNVBAGLBSA-N

Chemical Details
Formal Charge	0
Atom Count	31
Chiral Atom Count	1
Bond Count	32
Aromatic Bond Count	13

Drug Info: DrugBank

DrugBank ID	DB05289 ?
Name	Tarenflurbil
Groups	investigational
Description	Tarenflurbil is an investigational drug that was studied in patients with mild Alzheimer's disease. It is a selective amyloid lowering agent (SALA) that reduces levels of the toxic peptide amyloid beta 42 (Aβ42) in cultured human cells and in animal models. Aβ42 is the primary initiator of neurotoxicity and amyloid plaque development in the brains of Alzheimer's disease patients. In June 2008 development of the drug for Alzheimer's disease was discontinued. Tarenflurbil has also been used in trials studying the treatment of Prostate Cancer.
Synonyms	(R)-flurbiprofen (R)-2-fluoro-α-methyl(1,1'-biphenyl)-4-acetic acid (2R)-2-(2-fluorobiphenyl-4-yl)propanoic acid (?)-(2R)-2-(2-fluorobiphenyl-4-yl)propanoic acid Tarenflurbil
Indication	Investigated for use/treatment in alzheimer's disease and prostate cancer.
Categories	Acids, Acyclic Analgesics Analgesics, Non-Narcotic Anti-Inflammatory Agents Antirheumatic Agents Benzene Derivatives Biphenyl Compounds Central Nervous System Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Gamma Secretase Inhibitors and Modulators Peripheral Nervous System Agents Propionates Sensory System Agents
CAS number	51543-40-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
NF-kappa-B essential modulator	MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPET...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682